- Shares of Oramed Pharmaceuticals (ORMP) are down 13% on average volume today as the sell-off continues from its recent parabolic up move that began on December 20.
- Prices rocketed 360% on investors' brief enthusiasm over its insulin pill only to quickly retreat after various observers began scrutinizing the situation.
- Oramed's market cap is $121M.
- Six mutual funds have positions, up from two a year earlier.
From other sites
at 4-traders.com (Mar 24, 2015)
at CNBC.com (Jan 28, 2014)
at CNBC.com (Dec 26, 2013)
at MarketWatch.com (Dec 26, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs